Scientific publications for BioPredictive non-invasive diagnostics

Peer-reviewed studies validating BioPredictive blood-test diagnostics for liver disease — from first-in-class development cohorts to long-term meta-analyses.

9/433 Publications

False positive/negative Clear all

  1. Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age.

    Poynard T et al. · BMC Gastroenterol · 2011

    ActiTest FibroTest Alcohol HBV +4

  2. Evaluation of FibroTest-ActiTest in children with chronic hepatitis C virus infection.

    Hermeziu B et al. · Gastroenterol Clin Biol · 2010

    ActiTest FibroTest HCV

  3. Assessment of liver fibrosis: noninvasive means.

    Poynard T et al. · Saudi J Gastroenterol · 2008

    FibroTest Alcohol HBV HCV +3

  4. Biomarkers of liver fibrosis.

    Poynard T et al. · Adv Clin Chem · 2008

    ActiTest FibroTest SteatoTest Alcohol +5

  5. FibroMAX: towards a new universal biomarker of liver disease?

    Morra R et al. · Expert Rev Mol Diagn · 2007

    ActiTest AshTest FibroTest NashTest +7

  6. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C.

    Poynard T et al. · Comp Hepatol · 2004

    ActiTest FibroTest HCV

  7. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

    Poynard T et al. · Clin Chem · 2004

    ActiTest FibroTest HCV

  8. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Key publication

    Imbert-Bismut F et al. · Lancet · 2001

    FibroTest HCV

  9. Poynard T, Imbert-Bismut F, Ratziu V

    ActiTest FibroTest HBV HCV

Showing the full result list. The page is server-rendered and not paginated.